YCMGA
MDCO

York Capital Management Global Advisors’s Medicines Co MDCO Stock Holding History

York Capital Management Global Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-75,000
Closed -$3.67M – 86
2017
Q1 		$3.67M Buy
+75,000
New +$3.42M 0.09% 66

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

York Capital Management Global Advisors's MDCO Position: Q2 2017 in Review

York Capital Management Global Advisors sold out of Medicines Co (MDCO) in Q2 2017, closing a stake of 75,000 shares — an estimated $3.67M sold.

York Capital Management Global Advisors first reported a position in MDCO in Q1 2017 and held it in 1 quarter. The position peaked at $3.67M in Q1 2017. 202 funds tracked by Wall St. Rank hold MDCO as of Q2 2017.

  • York Capital Management Global Advisors reported no remaining Medicines Co position as of Q2 2017 after selling out during the quarter.
  • York Capital Management Global Advisors sold 75,000 Medicines Co shares in Q2 2017, an estimated $3.67M.
  • York Capital Management Global Advisors first reported a position in Medicines Co in Q1 2017 and held it in 1 quarter.
  • York Capital Management Global Advisors's Medicines Co position peaked at $3.67M in Q1 2017.
  • 202 funds tracked by Wall St. Rank held Medicines Co as of Q2 2017.

Based on York Capital Management Global Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.